Spironolactone Tablet
Product Images NDC 59651-426

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 59651-426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Spironolactone Fig1)

A Kaplan-Meier survival curve comparing probability over time in months between two groups: one treated with spironolactone and the other with placebo. The chart shows higher survival probability over 42 months for the spironolactone group. Statistical significance is indicated with a log-rank p-value less than 0.001.*

FDA Label Image

Fig2 (Spironolactone Fig2)

A forest plot chart depicting hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups including age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACEI use, and beta blocker use. It compares Spironolactone versus placebo effectiveness, with a horizontal axis ranging approximately from 0.2 to 1.4, indicating where Spironolactone is better versus placebo.*

FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

The packaging label for SPIRONOLACTONE Tablets, USP 25 mg, oral tablets, shows a 100 tablet count. Distributed by Aurobindo Pharma USA, Inc., the label indicates the product is made in India. It includes storage instructions (20° to 25°C) and a note to see accompanying prescribing information. The NDC is 59651-426-01.*

FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))

Label for Spironolactone Tablets USP 50 mg, oral tablets in a 100-tablet package by Aurobindo Pharma Limited. The label states each tablet contains 50 mg of spironolactone, includes storage instructions to protect from light and store at 20° to 25°C, and indicates distribution by Aurobindo Pharma USA, Inc. with manufacturing in India. The NDC is 59651-427-01.*

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablets Bottle))

Label for Spironolactone Tablets USP 100 mg oral tablets, containing 100 tablets per package. The label includes the National Drug Code (NDC 59651-428-01), manufacturer information (Aurobindo Pharma USA, Inc.), storage instructions, and dispensing warnings. The label is marked Rx only and highlights the 100 mg strength in yellow.*

FDA Label Image

Str1 (Spironolactone Str1)

Chemical structure of spironolactone, showing its steroid nucleus with attached lactone and thioacetate functional groups, representing the active ingredient of the drug spironolactone tablets by Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.